All In Biotech

Free tool

FAERS Monitor: Forfivo Xl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022497 or its brand name (Forfivo Xl, Bupropion Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

17,189

Serious

10,285

60% of reports

Hospitalization

4,314

Death reported

1,996

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,998
  • headache1,498
  • fatigue1,404
  • depression1,350
  • nausea1,207
  • off label use1,072
  • pain988
  • intentional overdose897
  • anxiety886
  • drug interaction864
  • rash849
  • toxicity to various agents823
  • completed suicide787
  • dizziness768
  • overdose741

Reports by year received

View as table
YearReports
2004183
2005196
2006169
2007246
2008317
2009303
2010209
2011387
2012565
2013302
2014323
2015334
2016403
2017659
2018527
2019806
2020776
20211,240
20221,749
20231,733
20242,452
20251,843
20261,467

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,970 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intentional overdoseSignal89717.316.313,646
completed suicideSignal78711.710.97,615
depressionSignal1,3507.36.97,366
drug interactionSignal8646.76.34,189
toxicity to various agentsSignal8236.05.63,432
overdoseSignal7414.23.91,826
anxietySignal8863.83.61,860
headacheSignal1,4982.92.81,954
rashSignal8492.42.2695
fatigueSignal1,4042.22.1962
pain9882.01.9484
dizziness7681.91.8326
nausea1,2071.91.8504
drug ineffective1,9981.91.8840
off label use1,0721.51.4185

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.